[18F]LW223 has low non-displaceable binding in murine brain, enabling high sensitivity TSPO PET imaging

Agne Knyzeliene, Mark G MacAskill, Carlos J Alcaide-Corral, Timaeus E. F. Morgan, Martyn C. Henry, Christophe Lucatelli, Sally L. Pimlott, Andrew Sutherland, Adriana A S Tavares

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Neuroinflammation is associated with a number of brain diseases, making it a common feature of cerebral pathology. Among the best-known biomarkers for neuroinflammation in Positron Emission Tomography (PET) research is the 18kDa translocator protein (TSPO). This study aims to investigate the binding kinetics of a novel TSPO PET radiotracer, [18F]LW223, in mice and specifically assess its volume of non-displaceable binding (VND) in brain as well as investigate the use of simplified analysis approaches for quantification of [18F]LW223 PET data. Adult male mice were injected with [18F]LW223 and varying concentrations of LW223 (0.003-0.55 mg/kg) to estimate VND of [18F]LW223. Dynamic PET imaging with arterial input function studies and radiometabolite studies were conducted. Simplified quantification methods, standard uptake values (SUV) and apparent volume of distribution (VTapp), were investigated. [18F]LW223 had low VND in the brain (<10% of total binding) and low radiometabolism (~15-20%). The 2-tissue compartment model provided the best fit for [18F]LW223 PET data, although its correlation with SUV90-120min or VTapp allowed for [18F]LW223 brain PET data quantification in healthy animals while using simpler experimental and analytical approaches. [18F]LW223 has the required properties to become a successful TSPO PET radiotracer.
Original languageEnglish
JournalJournal of Cerebral Blood Flow and Metabolism
Publication statusPublished - 5 Oct 2023


Dive into the research topics of '[18F]LW223 has low non-displaceable binding in murine brain, enabling high sensitivity TSPO PET imaging'. Together they form a unique fingerprint.

Cite this